RVX-208: A SMALL MOLECULE THAT INCREASES APOA-I, HDL-C, AND CHOLESTEROL EFFLUX

被引：1
|
作者：
Jahagirdar, R. [1 ]
Genest, J. [2 ]
Hansen, H. C. [1 ]
Nicholls, C. D. [1 ]
Attwell, S. [1 ]
McLure, K. G. [1 ]
Wagner, G. S. [1 ]
Johansson, J. [1 ]
Wong, N. C. [1 ]
机构：
[1] Resverlogix Corp, Pharmacol, Calgary, AB, Canada
[2] McGill Univ, Montreal, PQ, Canada
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(08)70007-2
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [31] Therapies to Increase ApoA-I and HDL-Cholesterol Levels
    Brown, William M.
    Chiacchia, Fabrizio S.
    DRUG TARGET INSIGHTS, 2008, 3 : 45 - 54
  • [32] HDL-cholesterol: Is it really good? Differences between apoA-I and HDL
    Santos-Gallego, Carlos G.
    Ibanez, Borja
    Badimon, Juan J.
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (04) : 443 - 452
  • [33] RVX-208 a Small Molecule That Induces Apolipoprotein A-I Production Progresses to Phase Ib/IIa Clinical Trials
    Gordon, Allan
    Jahagirdar, Ravi
    Johansson, Jan
    Wagner, Gregory
    Bailey, Dana
    Hansen, Henrik
    McLure, Kevin
    Krimbou, Larbi
    Genest, Jacques, Jr.
    Wong, Norman C. W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A205 - A205
  • [34] RVX-208, an orally active BET inhibitor, lowers CVD risk by activities beyond raising ApoA-1/HDL
    Kulikowski, E.
    Tsujikawa, L.
    Gilham, D.
    Wasiak, S.
    Halliday, C.
    Lebioda, K.
    Johansson, J.
    Sweeney, M.
    Wong, N.
    EUROPEAN HEART JOURNAL, 2015, 36 : 261 - 261
  • [35] CHOLESTEROL EFFLUX TO APOA-I, HDL2, AND SERUM FROM MACROPHAGES ISOLATED FROM LOW AND HIGH HDL SUBJECTS
    Vikstedt, R.
    Nakanishi, S.
    Soderlund, S.
    Ehnholm, C.
    Kovanen, P.
    Jauhiainen, M.
    Taskinen, M. -R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 21 - 21
  • [36] Effect of apoA-I mutations in the capacity of reconstituted HDL to promote ABCG1-mediated cholesterol efflux
    Daniil, G.
    Zannis, V. I.
    Chroni, A.
    FEBS JOURNAL, 2013, 280 : 153 - 153
  • [37] Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression
    Thorngate, FE
    Yancey, PG
    Kellner-Weibel, G
    Rudel, LL
    Rothblat, GH
    Williams, DL
    JOURNAL OF LIPID RESEARCH, 2003, 44 (12) : 2331 - 2338
  • [38] THE ABILITY TO DONATE LIPID-FREE APOA-I AS A PRIMARY CHOLESTEROL ACCEPTOR AT CHOLESTEROL EFFLUX IS A NEW FUNCTIONAL PROPERTY OF HDL
    Dergunov, A. D.
    Baserova, V. B.
    Litvinov, D. Y.
    ATHEROSCLEROSIS, 2022, 355 : E152 - E152
  • [39] Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
    Daniil, Georgios
    Zannis, Vassilis I.
    Chroni, Angeliki
    PLOS ONE, 2013, 8 (06):
  • [40] Role of HDL phospholipid in efflux of cell cholesterol to whole serum: Studies with human apoA-I transgenic rats
    Fournier, N
    Moya, MD
    Burkey, BF
    Swaney, JB
    Paterniti, J
    Moatti, N
    Atger, V
    Rothblat, GH
    JOURNAL OF LIPID RESEARCH, 1996, 37 (08) : 1704 - 1711
12345